Serum Institute’s Covishield vaccine may be recommended for international use2 min read . Updated: 18 Jan 2021, 02:41 PM IST
- AstraZeneca is engaging with governments, multilateral organisations and other partners around the world for broad and equitable access to the vaccine without profit for the duration of the pandemic.
NEW DELHI : Pune-based Serum Institute of India’s (SII) Covishield vaccine developed by Oxford University and AstraZeneca, which recently got Indian drug regulator’s nod for use in covid-19 vaccination drive in India, may also get a green signal for global use from the World Health Organisation (WHO).
Select your Category